DGX ▼ -0.0% - Quest Diagnostics Incorporated
$DGX - Haystack MRD® Demonstrates Robust Clinical Performance in Specimen Cohort from the Landmark DYNAMIC Colorectal Cancer Trials
01-OCT-2026 08:52 AM ET
Share this post
More filings for $DGX
DGX ▼ -0.0% - Quest Diagnostics IncorporatedOct 1, 2026DGX ▼ -4.1% - Quest Diagnostics IncorporatedSep 22, 2026DGX ▲ +0.3% - Quest Diagnostics IncorporatedSep 16, 2026DGX ▲ +0.5% - Quest Diagnostics IncorporatedSep 9, 2026DGX - Quest Diagnostics Incorporated - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $DGX filing history →💬 Comments
Loading comments…
Leave a comment